04:11 PM EDT, 10/07/2025 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said late Tuesday it launched a public offering of common shares.

The company will grant underwriters a 30-day overallotment option to buy up to an additional 15% of the shares offered, according to a statement.

Esperion shares fell 17% during after-hours activity.